| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| J7HA13 | NANOGP8; Fragment; | NANOGP8; | NULL | 130 | human |
| A0A024RAV3 | HCG1654716, isoform CRA_a; | NULL | NULL | 93 | human |
| Q3YB49 | Breast and ovarian cancer susceptibility protein; Fragment; | BRCA1; | NULL | 39 | human |
| E9PBZ9 | Nucleoside diphosphate-linked moiety X motif 6; | NUDT6; | NULL | 104 | human |
| I3L295 | Mannose-P-dolichol utilization defect 1 protein; | MPDU1; | NULL | 109 | human |
| B4DLR6 | Protocadherin-18; cDNA FLJ57393, highly similar to Protocadherin-18; | PCDH18; | NULL | 315 | human |
| Q8N0W1 | Seven transmembrane helix receptor; | NULL | NULL | 211 | human |
| Q6L638 | ABO glycosyltransferase; ABO-glycosyltransferase B; Fragment; | ABO; | NULL | 229 | human |
| J3QKN1 | FXYD domain containing ion transport regulator 6, isoform CRA_b; FXYD domain-containing ion transport regulator 6; | FXYD6; | NULL | 90 | human |
| J7HBD5 | Retinoic acid early transcript 1H; Fragment; | RAET1H; | NULL | 93 | human |
| Q8HC09 | Cytochrome c oxidase subunit 1; EC 1.9.3.1; Fragment; | NULL | NULL | 98 | human |
| B0QZ36 | mRNA export factor; Fragment; | RAE1; | NULL | 137 | human |
| A0A024R5Q9 | HCG1982563; HCG1982564; | NULL | NULL | 122 | human |
| C4N362 | KIR3DL1; KIR3DL1/S1; | KIR3DL1; | NULL | 444 | human |
| A0A024RBM7 | PR domain zinc finger protein 4; PR domain-containing protein 4; | PRDM4; | NULL | 801 | human |
| A0A024RDV4 | START domain containing 13, isoform CRA_a; | STARD13; | NULL | 1113 | human |
| E0X074 | KIR3DL1; | KIR3DL1; | NULL | 444 | human |
| H9QIJ3 | Cytochrome c oxidase subunit 3; | COX3; | NULL | 261 | human |
| A0A024QZE8 | Phosphorylase kinase, gamma 2 (Testis), isoform CRA_a; | PHKG2; | NULL | 297 | human |
| Q5Y7A3 | Duffy antigen chemokine receptor; Duffy antigen/chemokine receptor; Duffy antigen/chemokine receptor isoform a; Duffy blood group; | FY; DARC; | NULL | 338 | human |
